Business and Finance

Professor Laura Empson pulls back the curtain on insecure overachieving professionals and explains how they can come to accept damaging patterns of overwork as inevitable and even desirable

Financial commitment expected to benefit capabilities of single-use assemblies

Allows CDMO’s regulatory, consulting services to further expand into the pharma market

Among goals, product aims to mitigate supply chain risk for pharma and biotech industries

Location expands company’s pharmacovigilance, regulatory affairs services

Professor Barry Nalebuff of the Yale School of Management explains what is really at stake in any negotiation and ensures you get your half

Chandra Briggman talks about her achievements and future plans as president and CEO of Activation Capital, which supports local and regional efforts to grow a high-growth entrepreneurship community in the Richmond, VA area

Partnership adds technological offerings to PharmaLex’s repertoire

In deal to be finalized by October, purchases B Medical Systems for $423 million

Exploring the competitive and unique offerings in three of the US’s lower-cost economic development regions—and how success in these areas has been boosted by COVID

A look into one of the East Coast’s major life science hubs

Contract sales organizations are evolving alongside the companies they serve

Acquisition expands high-potent capabilities, along with oral development and manufacturing capacity

Acquisition of healthcare logistics company to play a role in delivery of pharma and biologic treatments

Division will operate under SCHOTT Pharma AG & Co. KGaA

How cross-functional commercialization teams can hone their role within clinical management pathways, communicate value to all stakeholders, achieve excellence in evidence generation, and maximize the opportunities of digital technologies

Price tag for bivalent dose was $1.74 billion

New 154,000 square-foot center will house several of the pharma company’s business units

New property is valued at $323 million

Focus on operational excellence is playing a major role in this effort, company says

CDMO’s Ireland campus will increase in capacity by 50% as a result

Expanded partnership revolves around hemophilia A therapeutics

Transaction totals about $3 billion

Project is expected to grow CRDO’s capacity by over 150,000 square feet

Facility, with expected completion of 2025, will specialize in mRNA-based therapies

Maria Whitman, global head of ZS’s pharmaceutical and biotech practice, talks about the upheaval of the pharma business model and what it means for sales reps; the current skills gap in the marketplace; and how mega-mergers could soon be back on the agenda

Deal expands CDMO’s presence in Europe

Investment will grow manufacturing capabilities at Winchester site

East Syracuse site will serve as a hub for company’s US biologics CDMO business

Deal establishes company’s presence in Mexico